Gestational Trophoblastic Disease

Making an Appointment

Call to schedule an appointment or contact us online

If you or your loved one has been diagnosed with gestational trophoblastic disease (GTD), Memorial Sloan-Kettering Cancer Center is ready to help. Our experienced team of doctors, nurses, and other healthcare professionals who treat GTD is dedicated to providing the highest quality treatment, counseling, and screening for patients with this disease.

In this section, you can find information about our expertise in treating patients with gestational trophoblastic disease, our services, and our research.

Our Approach & Expertise
Memorial Sloan-Kettering has a multidisciplinary team approach to providing the best possible treatment for women with gestational trophoblastic disease.
Overview
More than 80 percent of GTD cases are noncancerous. All forms of GTD can be treated, and in the great majority of cases the treatment results in a cure. Most women who have had a single incidence of GTD can go on to have normal pregnancies.
Risk Factors
Risk factors for gestational trophoblastic disease include age and prior history of the disease.
Symptoms
The most common symptoms of gestational trophoblastic disease are increased abdominal swelling, vaginal bleeding during pregnancy, and severe nausea and vomiting.
Diagnosis
A blood test for the human chorionic gonadotropin (HCG) hormone is most commonly used to diagnose gestational trophoblastic disease.
Treatment
Most forms of gestational trophoblastic disease can be cured with prompt management. Surgery and chemotherapy are the most common forms of treatment.
Survivorship & Support
Most women who have had gestational trophoblastic disease can have normal pregnancies later.

Site Map \| Index	Legal Disclaimer \| Privacy Practices \| Public Notices

©2009 Memorial Sloan-Kettering Cancer Center. 212-639-2000 1275 York Avenue New York, NY 10065.	PublicAffairs@mskcc.org